Evaluation and management of ultrafiltration problems in peritoneal dialysis

Peritoneal Dialysis International

Volumn 20, Issue SUPPL. 4, 2000, Pages

  Mujais, S ^a   Nolph, K ^a   Gokal, R ^a   Blake, P ^a   Burkart, J ^a   Coles, G ^a   Kawaguchi, Y ^a   Kawanishi, H ^a   Korbet, S ^a   Krediet, R ^a   Lindholm, B ^a   Oreopoulos, D ^a   Rippe, B ^a   Selgas, R ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ALBUMIN; AMINOGLYCOSIDE; AMINOPHYLLINE; AQUAPORIN; BETHANECHOL; BIOLOGICAL MARKER; CONTRAST MEDIUM; CREATININE; CYCLIC GMP; DEXTRAN 70; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIN; FUROSEMIDE; GLUCOSE; GLUCOSE TRANSPORTER; ICODEXTRIN; LACTIC ACID; LOOP DIURETIC AGENT; METOLAZONE; NEOSTIGMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATIDYLCHOLINE; RENIN; SODIUM ION; THIAZIDE DIURETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY MASS; CARDIOVASCULAR PERFORMANCE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIET THERAPY; DOSE RESPONSE; DRUG ACTIVITY; EDITORIAL; FLUID BALANCE; FLUID THERAPY; HEMODIALYSIS; HOMEOSTASIS; HUMAN; HYPERVOLEMIA; HYPOVOLEMIA; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MEDICAL ASSESSMENT; MEMBRANE TRANSPORT; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PATIENT MONITORING; PERITONEAL DIALYSIS; PERITONITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RAT; ULTRAFILTRATION;

EID: 0033659920     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080002004s02     Document Type: Editorial

References (104)

1. Fluid management and cardiovascular outcome in peritoneal dialysis patients
2. Effect of continuous ambulatory peritoneal dialysis on blood pressure control
3. Have we underestimated the importance of fluid balance for the survival of PD patients
4. Audit of antihypertensive treatment in patients with renal failure
5. Prevalence of hypertension in patients on peritoneal dialysis: Results of an Italian multicentre study
6. Issues affecting the longevity of the continuous peritoneal dialysis therapy
7. Acute complications during hemodialysis
8. Complications during hemodialysis
9. The influence of dialysis treatment modality on the decline of remaining residual renal function
10. Commonly prescribed salt intake in continuous ambulatory peritoneal dialysis is too restrictive: Results of a double-blind crossover study
11. Timely initiation of dialysis by DOQI guidelines: Maintenance of residual renal function
12. Frusemide increases urine volume but does not preserve residual renal function in patients on CAPD - Results of a six months randomized controlled study
13. Ultrafiltration management in automated peritoneal dialysis
14. Loss of ultrafiltration in continuous ambulatory peritoneal dialysis. A role for acetate
15. Restoration of ultrafiltration capacity of peritoneal membrane in patients on CAPD
16. Clinical significance of ultrafiltration failure on CAPD
17. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity
18. Pathophysiology of ultrafiltration in peritoneal dialysis
19. Investigation and management of ultrafiltration failure in CAPD
20. Causes, diagnosis, and treatment of peritoneal membrane failure
21. Workup of ultrafiltration failure
22. Management of peritoneal catheter malfunction
23. Investigation and treatment of poor drains of dialysate fluid associated with anterior abdominal wall leaks in patients on chronic ambulatory peritoncal dialysis
24. Computed tomographic peritoneography: CT manifestations in the investigation of leaks and abnormal collections in patients on CAPD
25. Peritoneography and peritoneal computerized tomography: A new approach to noninfectious complications of CAPD
26. Complications of peritoneal dialysis: Evaluation with CT peritoneography
27. Early and late peritoneal leaks in patients on CAPD
28. Computerized tomography CT in the diagnosis of subcutaneous leak sites during continuous ambulatory peritoneal dialysis (CAPD)
29. Computerized tomographic scanning with intraperitoneal contrast enhancement in a CAPD patient with localized edema
30. Colloid peritoneoscintigraphy in complications of CAPD
31. Prospective peritoneal scintigraphy in patients beginning continuous ambulatory peritoneal dialysis
32. Migration of peritoneal catheters: Personal experience and survey of 72 other units
33. Peritoneal equilibration test
34. The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients
35. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis
36. Equilibration of peritoneal dialysis solutions during long-dwell exchanges
37. Comparison of fast peritoneal equilibration tests with 1.36 and 3.86% dialysis solutions
38. Stability of the peritoneal membrane in long-term peritoneal dialysis patients
39. Peritoneal solute transport predicts survival on CAPD independently of residual renal function
40. Increased peritoneal transport is associated with decreased CAPD technique and patient survival
41. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients
42. Characteristics of peritoneum after peritonitis in peritonitis in CAPD patients
43. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients
44. Continuous mesothelial injury and regeneration during long-term peritoneal dialysis
45. Mesothelial regeneration after peritonitis in dialysis patients
46. Icodextrin use in CCPD patients during peritonitis: Ultrafiltration and serum disaccharide concentrations
47. Peritoneal transport characteristics of water, low molecular weight solutes and proteins during long-term continuous ambulatory peritoneal dialysis
48. Indices of peritoneal permeability and surface area
49. Impact of surface area and permeability on solute clearances
50. Prevention and treatment of peritoneal dialysis membrane failure
51. Longitudinal follow-up of CA 125 in peritoneal effluent
52. Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis
53. Role of acetate in loss of ultrafiltration during CAPD
54. Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study
55. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis
56. A longitudinal, five year survey of urea kinetic parameters in CAPD patients
57. A prospective study of peritoneal transport in CAPD patients
58. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years
59. Peritoneal permeability and encapsulating peritonitis
60. The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis
61. Peritoneal sclerosis in chronic peritoneal dialysis patients: Analysis of clinical presentation, risk factors and peritoneal transport kinetics
62. Sclerosing peritonitis: Identification of diagnostic, clinical and radiological features
63. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis
64. Lymphatic absorption in CAPD patients with loss of ultrafiltration capacity
65. Use of dextran 70 to estimate peritoneal lymphatic absorption rate in CAPD
66. Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70
67. Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD?
68. Simulations of peritoneal solute transport during CAPD. Application of two pore formalism
69. Computer simulations of peritoneal transport in CAPD
70. Clinical implication of a three pore model of peritoneal transport
71. Peritoneal physiology - Transport of solutes
72. A phenomenological interpretation of the variation in dialysate volume with dwell time in CAPD
73. Net fluid absorption under membrane transport models of peritoneal dialysis
74. Peritoneal transport physiology: Insights from basic research
75. Regulation and localisation of peritoneal aquaporins expression during long-term peritoneal dialysis in rats
76. Reduced osmotic water permeability of the peritoneal barrier in AQP1 knockout mice; AQP1 provides a 'water-only' pathway in peritoneal dialysis
77. In vivo inhibition of transcellular water channels (aquaporin-1) during acute peritoneal dialysis in rats
78. Demonstrations of aquaporin-CHIP in peritoneal tissue of uremic and CAPD patients
79. Water channels in the peritoneum
80. Expression of aquaporin-1 (AQP1) in a long-term peritoneal dialysis patient with impaired transcellular water transport
81. Sieving and reflection coefficients for sodium salts and glucose during peritoneal dialysis
82. Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis
83. Correcting sodium sieving for diffusion from the circulation
84. Predictors of loss of residual renal function among new dialysis patients
85. Peritoneal resting and heparinization as an effective treatment for ultrafiltration failure in patients on CAPD
86. Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure
87. Result of peritoneal membrane (PM) resting (R) on dialysate (d) CA125 levels and PET results
88. Improvement of transcellular water transport by treatment with glucose free dialysate in patients with ultrafiltration failure
89. The effect of glucose polymers on water removal and protein clearances during CAPD
90. Peritoneal transport characteristics with glucose polymer based dialysate
91. Icodextrin: Overview of clinical experience
92. Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume
93. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysis creatinine clearance
94. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis
95. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: Extension of technique survival
96. Preserving the peritoneal dialysis membrane in long-term peritoneal dialysis patients
97. The peritoneal membrane in chronic peritoneal dialysis
98. Icodextrin's effects on peritoneal transport
99. Theoretical analysis of osmotic agents in peritoneal dialysis: What size is an ideal osmotic agent?
100. Pharmacological reduction of lymphatic absorption from the peritoneal cavity increases net ultrafiltration and solute clearances in peritoneal dialysis
101. Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis
102. Influence of phosphatidylcholine on lymphatic absorption during peritoneal dialysis in the rat
103. Effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis
104. Use of bethanechol chloride to increase available ultrafiltration in CAPD